|
SCD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4597003867608E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.19510001473611E-09 |
| Normal-vs-Stage2 |
2.277700E-02 |
| Normal-vs-Stage3 |
1.12059999946013E-07 |
| Normal-vs-Stage4 |
1.70350999999513E-05 |
| Stage1-vs-Stage2 |
1.001630E-01 |
| Stage1-vs-Stage3 |
1.909190E-01 |
| Stage1-vs-Stage4 |
1.466010E-01 |
| Stage2-vs-Stage3 |
2.265800E-02 |
| Stage2-vs-Stage4 |
2.260300E-02 |
| Stage3-vs-Stage4 |
6.701200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.5564994565741E-11 |
| Normal-vs-AfricanAmerican |
1.640260E-02 |
| Normal-vs-Asian |
2.33679999994685E-06 |
| Caucasian-vs-AfricanAmerican |
3.526400E-01 |
| Caucasian-vs-Asian |
3.959500E-02 |
| AfricanAmerican-vs-Asian |
9.520400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.48930000238346E-08 |
| Normal-vs-Female |
1.98109995075413E-09 |
| Male-vs-Female |
7.090200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46440000126091E-08 |
| Normal-vs-Age(41-60Yrs) |
1.45350000035904E-07 |
| Normal-vs-Age(61-80Yrs) |
3.52209999999742E-05 |
| Normal-vs-Age(81-100Yrs) |
4.398200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.677800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.656600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.364400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.060000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.986440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.684400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.173000E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
2.409300E-04 |
| Classical-VS-Normal |
1.70641278884887E-12 |
| Tall-VS-Follicular |
1.41020000121728E-08 |
| Tall-VS-Other |
1.264250E-03 |
| Tall-VS-Normal |
8.48840000511331E-08 |
| Follicular-VS-Other |
1.648230E-01 |
| Follicular-VS-Normal |
6.796600E-01 |
| Other-VS-Normal |
3.594600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32870000002505E-06 |
| Normal-vs-N1 |
1.023150E-04 |
| N0-vs-N1 |
9.268100E-02 |
|
|
